Novozymes streamlines its supply chain activities in Denmark
04-May-2006
According to Novozymes, a comparison of the savings from the planned process and efficiency improvements with the costs of moving the supply chain activities to countries with lower production costs shows that it can still be profitable to keep these activities in Denmark.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.